P3-342: RELATION BETWEEN MEDIAL TEMPORAL LOBE MORPHOLOGY AND COGNITIVE CHANGE: ONE YEAR FOLLOW UP DATA FROM THE TATA LONGITUDINAL STUDY OF AGING

Introduction: The radiographic control of the root canal treatment can evaluate the healing of the periapical lesions. The objective of this study was to determinate the characteristics of the radiographic healing that was observed after one year, during follow-up sessions; so, the healing of the lesions according to the periapical pathology at the beginning of the treatment and the causes of failure of the endodontic treatments were recorded.Method: This is a prospective, observational, descriptive and longitudinal study, carried out in patients who attended control one year after endodontic treatment through the Periapical Index (PAI).Results: A total of 395 teeth of patients who underwent endodontic treatment one year prior to data collection, 87 presented radiogaphically observable periapical lesions; of these, 40 (45.97%) attended the control at one year. The frequency of cases in which some degree of radiographic healing was observed one year after treatment was 97.46%. The pathology with more cases of complete healing was periodontitis with sinus tract. In general, 84.61% of the cases decreased two levels in their PAI after one year. The 100% of the cases of failure presented vertical root fractures.Conclusion: The frequency of periapical healing after endodontic treatment is high. The main cause for the failure of the treatments documented in this study was the lack of coronal restoration that caused vertical fractures.

Download Full-text

A longitudinal study of cerebrospinal fluid beta-endorphin-like immunoreactivity in delirium: changes at the acute stage and at one-year follow-up

Acta Psychiatrica Scandinavica ◽

10.1111/j.1600-0447.1990.tb01394.x ◽

1990 ◽

Vol 82 (4) ◽

pp. 323-326 ◽

Cited By ~ 11

Author(s):

H. Koponen ◽

J. Riekkinen

Keyword(s):

Cerebrospinal Fluid ◽

Longitudinal Study ◽

Acute Stage ◽

Beta Endorphin ◽

One Year

Download Full-text

P-1220 - Cognitive reserve predicts insight in psychosis when cannabis use moderate this relation: a longitudinal study one year follow-up

European Psychiatry ◽

10.1016/s0924-9338(12)75387-7 ◽

2012 ◽

Vol 27 ◽

pp. 1

Author(s):

J. Cartón Costa ◽

A. García Guerrero ◽

J.I. Eguíluz Uruchurtu ◽

I. Querejeta Ayerdi ◽

E. Bengoetxea Noreña ◽

...

Keyword(s):

Longitudinal Study ◽

Cognitive Reserve ◽

Cannabis Use ◽

One Year

Download Full-text

Remembering one year later: Role of the amygdala and the medial temporal lobe memory system in retrieving emotional memories

Proceedings of the National Academy of Sciences ◽

10.1073/pnas.0409848102 ◽

2005 ◽

Vol 102 (7) ◽

pp. 2626-2631 ◽

Cited By ~ 328

Author(s):

F. Dolcos ◽

K. S. LaBar ◽

R. Cabeza

Keyword(s):

Temporal Lobe ◽

Medial Temporal Lobe ◽

Memory System ◽

Emotional Memories ◽

One Year

Download Full-text

Medial temporal lobe subregional atrophy in ageing and Alzheimer’s disease: A longitudinal study

Alzheimer s & Dementia ◽

10.1002/alz.051783 ◽

2021 ◽

Vol 17 (S1) ◽

Author(s):

Lea Chauveau ◽

Elizabeth Kuhn ◽

Vincent De la Sayette ◽

Gaël Chetelat ◽

Robin de Flores

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Longitudinal Study ◽

Temporal Lobe ◽

Medial Temporal Lobe

Download Full-text

Does How We Remember Predict How We Will Feel? A Longitudinal Study of the Influence of Overgeneral Memory on the Development of Depression in Young People

10.26686/wgtn.17007691.v1 ◽

2021 ◽

Author(s):

◽

Zara Mansoor

Keyword(s):

Depressive Symptoms ◽

Longitudinal Study ◽

Young People ◽

Longitudinal Research ◽

Community Sample ◽

Future Directions ◽

Overgeneral Memory ◽

One Year ◽

Over Time

<p>An increased tendency towards overgeneral memory (OGM) has been associated with depression in young people. How this may impact the early development of depressive symptoms is unclear. This has been difficult to determine due to the lack of longitudinal research in this area, in particular with young people in the community prior to the development of significant depressive symptoms. The current study aimed to investigate how OGM related to the development of depression in a community sample of 235 young people aged 10- to 15-years at baseline. Measures of depression, OGM, and rumination were obtained at baseline and follow-up, one year later. As predicted, and consistent with past findings, an increased tendency towards OGM at follow-up was associated with greater depressive symptoms. However, despite indications from previous work that OGM may also predict depression prior to the emergence of symptoms, the reverse was found with depression predicting OGM over time. This suggests that among the general population, while OGM may be an associated and possible maintaining feature of depression, it appears to be a consequence of experiencing depressive symptoms rather than a significant early predictive or vulnerability factor. Contrary to evidence that rumination may also increase OGM, rumination was not significantly associated with OGM. Limitations, strengths and future directions based on these findings are discussed.</p>

Download Full-text

Clobazam as Add-on Therapy for Temporal Lobe Epilepsy and Hippocampal Sclerosis

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ◽

10.1017/s0317167100016942 ◽

2005 ◽

Vol 32 (1) ◽

pp. 93-96 ◽

Cited By ~ 10

Author(s):

Maria Augusta Montenegro ◽

Claudio Meilman Ferreira ◽

Fernando Cendes ◽

Li M. Li ◽

Carlos A.M. Guerreiro

Keyword(s):

Temporal Lobe Epilepsy ◽

Temporal Lobe ◽

Seizure Control ◽

Hippocampal Sclerosis ◽

Maximum Tolerated Dose ◽

Minimum Effective Dose ◽

Inclusion Criteria ◽

First Line Therapy ◽

One Year

Background:Clobazam is a benzodiazepine with known antiepileptic action; however, it is not considered first line therapy in the treatment of epilepsy. The objective of this study was to evaluate the efficacy of clobazam as add-on therapy in adults with temporal lobe epilepsy associated with MRI evidence of hippocampal sclerosis (HS).Method:This is a retrospective study, conducted at our epilepsy clinic which evaluated clobazam as add-on therapy in patients with temporal lobe epilepsy and MRI signs of HS. Clobazam was prescribed based on the minimum effective dose up to the maximum tolerated dose.Results:Seventy-eight patients met the inclusion criteria (51 women), ages ranging from 16 to 76 years old (mean=42.2). Dosage of clobazam ranged from 5 to 60 mg/day (mean=22.6 mg/day). Clobazam was used from one month to eight years (mean=29 months). Sixteen (20.5%) patients were seizure-free, 20 (25.5%) had more than 75% improvement in seizure control, eight (10%) had more than 50% and 20 (26%) were non responders to clobazam. In 14 (18%) we could not determine seizure frequency during follow-up. The improvement in seizure control lasted for more than one year in 30 (68%) patients.Conclusion:Our data suggest that clobazam should be considered as add-on therapy in the treatment of patients with temporal lobe epilepsy associated with MRI signs of HS.

Download Full-text